Réactifs et instruments pour l'immunologie, la biologie cellulaire et la biologie moléculaire.
 
> Polymyxin B [1404-26-8]

Polymyxin B [1404-26-8]

Imprimer Imprimer
Identifiez-vous

Référence HY-149179-500mg

Conditionnement : 500mg

Marque : MedChemExpress

Demander plus d'informations

Contactez votre distributeur local :


Téléphone : +1 850 650 7790

Polymyxin B is an antibiotic. Polymyxin B inhibits Gram-negative infections by binding to the LPS of the bacterial wall with high affinity. Polymyxin B neutralizes the effect of endotoxin. Polymyxin B induces bacterial death by increasing its permeability. Polymyxin B is used in endotoxemia research.

Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.

Polymyxin B Chemical Structure

Polymyxin B Chemical Structure

CAS No. : 1404-26-8

This product is a controlled substance and not for sale in your territory.

Based on 10 publication(s) in Google Scholar

Other Forms of Polymyxin B:

  • Polymyxin B Sulfate In-stock

Voir tous les produits spécifiques à Isoform Antibiotic:

Voir toutes les isoformes
Aminoglycoside Glycopeptide Lipopeptide Macrolide Oxazolidinone Quinolone Tetracycline β-lactam
Description

Polymyxin B is an antibiotic. Polymyxin B inhibits Gram-negative infections by binding to the LPS of the bacterial wall with high affinity. Polymyxin B neutralizes the effect of endotoxin. Polymyxin B induces bacterial death by increasing its permeability. Polymyxin B is used in endotoxemia research[1][3].

In Vitro

Polymyxin B (10 μg/mL, 6 h) decreases the TNF-α and IL-10 production in Human peripheral blood mononuclear cells (PBMC) [3].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Polymyxin B Related Antibodies
In Vivo

Polymyxin B (5-20 mg/kg for i.v; once daily for seven days) reaches the nephrotoxicity endpoint at 20 mg/kg instead of 5 mg/kg in Sprague-Dawley rats model[2].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
CAS No.

1404-26-8
Appearance

Solid

Color

White to light yellow

SMILES

[Polymyxin B]
Livraison

Room temperature in continental US; may vary elsewhere.
Stockage
Powder -20°C 3 years
4°C 2 years
In solvent -80°C 6 months
-20°C 1 month
Solvant et solubilité
In Vitro: 

H2O : 33.33 mg/mL (ultrasonic and adjust pH to 2 with HCl)

  • Calculateur de molarité

  • Calculateur de dilution

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass
=
Concentration
×
Volume
×
Molecular Weight *

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Concentration (start)

C1

×
Volume (start)

V1

=
Concentration (final)

C2

×
Volume (final)

V2

In Vivo Dissolution Calculator
Please enter the basic information of animal experiments:

Dosage

mg/kg

Animal weight
(per animal)

g

Dosing volume
(per animal)

μL

Number of animals

Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
Calculation results:
Working solution concentration: mg/mL
This product has good water solubility, please refer to the measured solubility data in water/PBS/Saline for details.
The concentration of the stock solution you require exceeds the measured solubility. The following solution is for reference only.If necessary, please contact MedChemExpress (MCE).
Pureté et documentation

Purity: ≥91.0%

SDS (251 KB)

COA (243 KB)

Instruction de manipulation (2659 KB)
Références

  • [1]. Martin EL, et al. Endotoxin removal: how far from the evidence? The EUPHAS 2 Project. Contrib Nephrol. 2010;167:119-125.  [Content Brief]

    [2]. Manchandani P, et al.Role of Renal Drug Exposure in Polymyxin B-Induced Nephrotoxicity. Antimicrob Agents Chemother. 2017 Mar 24;61(4):e02391-16.  [Content Brief]

    [3]. Cardoso LS, et al.Polymyxin B as inhibitor of LPS contamination of Schistosoma mansoni recombinant proteins in human cytokine analysis. Microb Cell Fact. 2007 Jan 3;6:1.  [Content Brief]

  • [1]. Martin EL, et al. Endotoxin removal: how far from the evidence? The EUPHAS 2 Project. Contrib Nephrol. 2010;167:119-125.

    [2]. Manchandani P, et al.Role of Renal Drug Exposure in Polymyxin B-Induced Nephrotoxicity. Antimicrob Agents Chemother. 2017 Mar 24;61(4):e02391-16.

    [3]. Cardoso LS, et al.Polymyxin B as inhibitor of LPS contamination of Schistosoma mansoni recombinant proteins in human cytokine analysis. Microb Cell Fact. 2007 Jan 3;6:1.

  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.

Polymyxin B Related Classifications

  • Anti-infection
  • Bacterial Antibiotic
Help & FAQs

Keywords:

Polymyxin B1404-26-8BacterialAntibioticEndotoxemiaGram-negative infectionLPSNephrotoxicitySprague-Dawley ratsE. coliPBMCInhibitorinhibitorinhibit